rintatolimod

  1. Sly Saint

    Ampligen in Phase 2 Clinical Study for the Treatment of Post-COVID Conditions

    Several posts have been moved from this thread: Ampligen - Hemispherx Biopharma re ME/CFS not relating to ME but Covid-19 AIM ImmunoTech inks deal to research vaping device as a vehicle for Ampligen to treat coronavirus...
    • Sly Saint
    • Thread
    • aim ampligen double-blind phase ii randomized controlled trial rintatolimod
    • Replies: 36
    • Forum: Long Covid research
  2. cassava7

    A Double-Blind, Placebo-Controlled, Randomized, Clinical Trial of the TLR-3 Agonist Rintatolimod in Severe Cases of CFS, Strayer et al, 2012

    Background Chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) is a severely debilitating disease of unknown pathogenesis consisting of a variety of symptoms including severe fatigue. The objective of the study was to examine the efficacy and safety of a TLR-3 agonist, rintatolimod...
    • cassava7
    • Thread
    • ampligen phase iii randomized controlled trial rct rintatolimod
    • Replies: 15
    • Forum: ME/CFS research
  3. Andy

    Effect of disease duration in a randomized Phase III trial of rintatolimod, an immune modulator for [ME/CFS], 2020, Mitchell et al

    Rintatolimod = Ampligen Open access, https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0240403
    • Andy
    • Thread
    • 2020 ampligen me/cfs paper rintatolimod
    • Replies: 16
    • Forum: ME/CFS research
  4. Andy

    Leveraging Prior Knowledge of Endocrine Immune Regulation in the Therapeutically Relevant Phenotyping of Women With CFS, 2019, Morris et al

    Paywalled at https://www.clinicaltherapeutics.com/article/S0149-2918(19)30112-2/fulltext
    • Andy
    • Thread
    • 2019 cortisol cytokines endocrine regulation hpa axis immune regulation me/cfs morris numerical modeling paper rintatolimod rituximab
    • Replies: 9
    • Forum: ME/CFS research
Back
Top Bottom